AbleNet
Form 483 issued July 8, 2024 · Roseville, Minnesota
- Inspection
- Jun 26 – Jul 8, 2024
- Investigators
- Alicia U. Jacobo· Tyler R. Courtney
- Observations
- 8
- Pages
- 7
- FEI number
- 3001576173
In short: On July 8, 2024, FDA issued a Form 483 with 8 observations to AbleNet in Roseville, Minnesota (FEI 3001576173) after an inspection that ran Jun 26 – Jul 8, 2024. The investigators were Alicia U. Jacobo and Tyler R. Courtney. Most observations concern cAPA and management controls.
At a glance
CAPA and management controls account for 7 of 8 observations.
What FDA observed
Preview: the opening words of each observation- 01
Procedures for corrective and preventive action…
- 02
Procedures for receiving, reviewing, and evaluating complaints by a formally designated unit…
- 03
Procedures for quality audits…
- 04
Procedures for management review…
This inspection in context
Alicia U. Jacobo
4 documents · 2024–2026
Cites 803.17 (what are the requirements for developing, maintaining, and implementing written mdr procedures that apply to me?) more than any other section. Most of their documents are for sites in Minnesota.
The firmAbleNet history
The site's inspection history, in date order.
Similar 483sOther sites cited under 820.100(a)
See how FDA wrote the same problem up elsewhere.
Questions about this 483
What did FDA find at AbleNet?
FDA listed 8 observations on this Form 483, mostly about cAPA, management controls and production & process controls. The opening words of each observation are shown on this page.
Who inspected AbleNet?
Alicia U. Jacobo and Tyler R. Courtney are named on this Form 483, for the inspection of Jun 26 – Jul 8, 2024. Each investigator has a profile showing what they cite most.
When was AbleNet inspected by FDA?
The inspection ran Jun 26 – Jul 8, 2024, and the Form 483 is dated July 8, 2024.
How do I get the full Form 483 for AbleNet?
Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.